Case Reports in Pathology

Case Reports in Pathology / 2014 / Article

Case Report | Open Access

Volume 2014 |Article ID 189850 | https://doi.org/10.1155/2014/189850

A. Nael, P. J. Siaghani, D. Chen, S. G. Romansky, L. Shane, "Idiopathic Infantile Arterial Calcification: A Possible Cause of Refractory Cardiopulmonary Failure in Infancy", Case Reports in Pathology, vol. 2014, Article ID 189850, 4 pages, 2014. https://doi.org/10.1155/2014/189850

Idiopathic Infantile Arterial Calcification: A Possible Cause of Refractory Cardiopulmonary Failure in Infancy

Academic Editor: M. Mazzocchi
Received11 Dec 2013
Accepted02 Jan 2014
Published09 Feb 2014

Abstract

Idiopathic Infantile Arterial Calcification is a rare autosome recessive disease characterized by extensive calcification of medium and large arteries. Loss-of-function mutations in ectonucleotide pyrophosphatase/phosphodiesterase 1 gene have been described in more than 80% of the cases. Although the diagnosis is usually made at autopsy, it is possible to identify cases based on clinical presentation, radiology findings, and molecular studies. Appropriate treatment can be initiated and has been shown to successfully induce permanent remission. We report a 4-week-old neonate who initially presented with respiratory distress, heart failure, and Coxsackie B viremia suggestive of viral induced cardiomyopathy. His symptoms progressed to multiple organ failure and he eventually expired at four weeks of age. On autopsy, diffuse calcium deposition within the internal elastic lamina of medium and large arteries was identified, as well as narrowing of lumen due to myointimal proliferation. This case report will emphasize the importance of taking this rare curable disease into consideration in all cases of infants with cardiopulmonary failure.

1. Introduction

Idiopathic Infantile Arterial Calcification (IIAC) is a rare autosome recessive disease characterized by extensive calcification of medium and large arteries including the aorta, coronary arteries, and renal arteries. Loss-of-function mutation in ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) gene was found in 80% of cases [1]. The disease usually presents from in utero to 3-4 months of age with a wide spectrum of symptoms. The most common constellation of symptoms to raise the possibility of IIAC is respiratory distress, cyanosis, and heart failure [2]. However, rare cases with later presentations have been reported [1, 3]. Without appropriate treatment, IIAC has a high morbidity and mortality rate. On autopsy, calcifications of the large arteries are characteristic, but the most frequent gross findings are myocardial hypertrophy and firm tortuous coronary arteries [1]. Microscopically, diffuse calcium hydroxyapatite deposition within the internal elastic lamina of medium and large arteries with myointimal proliferation and stenosis is characteristic [4, 5].

2. Case Presentation

The patient was a 4-week-old male infant born at an estimated gestational age of 30 weeks with a birth weight of 1665 grams and APGAR scores of 8 and 9 at one and five minutes, respectively. Gross congenital anomalies were not identified. The mother was a gravida 3, para 2, abortion 1, 21-year-old African American with an adequate prenatal care. Her pregnancy was complicated by group b streptococcus urinary tract infection and placental abruption requiring pregnancy termination. In addition, there was a history of hand-foot-mouth syndrome in his sibling two weeks prior to delivery. Immediately after birth, the neonate developed respiratory distress and cyanosis requiring intubation and admission to the neonatal intensive care unit. The initial physical exam revealed a grade III-IV holosystolic murmur and generalized edema. The initial X-rays and echocardiographs demonstrated a moderate to large patent ductus arteriosus (PDA), moderate to severe pulmonary hypertension, and biventricular changes suggestive of hypertrophic cardiomyopathy. Bedside PDA ligation was performed. Subsequent studies revealed Coxsackie B viremia (confirmed by polymerase chain reaction (PCR)); however, TORCH serology were all negative. Viral induced hypertrophic cardiomyopathy was the presumptive diagnosis. However, daily chest X-rays demonstrated progressive nonspecific calcification of the chest soft tissue and the vessels of both arms (Figure 1). Despite multiple intravenous immunoglobulin treatments, loop diuretics, phosphodiesterase 3 inhibitor, and dopamine for the presumed viral induced cardiomyopathy, his symptoms progressed and the patient expired at 4 weeks of age secondary to intraventricular brain hemorrhage and multiorgan failure. At autopsy, there was severe anasarca, but gross congenital anomalies were not identified. Cardiovascular dissection revealed increased biventricular wall thickness (Figure 2(a)) with evidence of gross arterial calcification along the large vessels. Microscopic sections of the heart demonstrated cardiac myocyte nuclei enlargement consistent with hypertrophy and focal calcium deposition and fibrosis within the myocardium. However, inflammation suggestive of myocarditis could not be identified (Figures 2(b) and 2(c)). The coronary arteries demonstrated focal calcification of the internal elastic lamina (Figure 3), while sections from the ascending and descending aorta exhibited extensive calcification with disruption of the elastic lamina and intimal fibrosis (Figure 4). Other organs including lungs, brain, pancreas, kidneys, skin, muscles, and testicles also displayed extensive calcium deposition involving the internal elastic lamina with ingrowth of loose fibromyxoid tissue resulting in luminal narrowing and obstruction. The renal hilar vessels were extensively involved (Figure 5). The gross and microscopic features were consistent with the diagnosis of IIAC. In this case, Coxsackie B viremia and a history of hand-foot-mouth syndrome in the sibling as the etiology of the cardiopulmonary failure were a red herring. However, the single nucleotide polymorphism microarray analysis indicated no clinically significant abnormality and was consistent with a normal male chromosome complement, but the gene sequencing to evaluate the presence or absence of ENPP1 gene mutation was not performed. This case report aims to emphasize the importance of taking into consideration this rare but curable disease in infants presenting with refractory cardiopulmonary failure.

3. Discussion

Although most cases of IIAC are diagnosed at autopsy, there have been reports of diagnosis prior to death based on characteristic findings seen on imaging studies. These include arterial calcification, thickened myocardium, and aortic ring appearance caused by aortic wall calcification [6]. Furthermore, extravascular calcifications in the periarticular cartilage of large joints have been reported in many affected infants [7, 8]. Moreover, a few cases of IIAC discovered on prenatal ultrasound have also been reported by identifying signs of hydrops fetalis and cardiomegaly [9, 10]. Although infancy vascular calcifications are not unique to IIAC and other more common conditions such as hypervitaminosis D, parathyroid abnormalities, intrauterine infections, progeria, Williams’s syndrome, pseudoxanthoma elasticum, and Singleton-Merten syndrome should also be kept in mind [2]. However, these cases have different clinical presentations compared to IIAC. In our case the most challenging differential diagnosis was intrauterine fetal infection. Although each of the congenital intrauterine infections has distinct clinical manifestations and sequelae, some of them do share certain clinical features including microcephaly, intracranial calcifications, rash, intrauterine growth restriction, jaundice, hepatosplenomegaly, elevated transaminases, and thrombocytopenia [11]. None of which were present in our case. This in addition to the negative TORCH serology makes the classic group of congenitally acquired infections unlikely. Although Coxsackie B viremia was confirmed by PCR and presumed to be the etiology of the cardiomyopathy, microscopic sections on autopsy failed to demonstrate any evidence of inflammation and thus not supporting viral induced cardiomyopathy as the etiology of the cardiopulmonary failure. Cases clinically suspicious for IIAC can be confirmed with imaging studies, arterial biopsy, and molecular analysis [7, 12]. Early appropriate diagnosis would allow treatment with bisphosphonates, which have been shown to induce permanent remission by inhibiting disease progression and solubilizing calcium deposits with long-term survival [7, 1316]. The tendency of the disease to occur in siblings raised the prospect of genetic linkage, which has been supported by loss-of-function mutation affecting the ENPP1 gene with autosomal recessive transmission. The gene encoding ENPP1 spans 83 kb of genomic DNA and contains 25 exons [8]. About forty different mutations either in homozygote or compound heterozygote have been identified in the ENPP1 gene linked to IIAC [7]. Rutsch et al. [7, 8, 17] demonstrated that extracellular matrix calcification in IIAC is a default process due to deficiency in inorganic pyrophosphate (PPi). PPi is known as one of the major inhibitors of hydroxyapatite crystal deposition and chondrogenesis in bone and cartilage. In summary, PPi level in plasma and urine is regulated by multiple pathways including ENPP1 gene function. ENPP1 gene mutation leads to decreased activity in its downstream product, nucleotide pyrophosphatase 1 (NPP1). Deficiency of NPP1 activity will lead to less PPi generation. Bisphosphonates are PPi analogues, which would explain reports of remission in cases of IIAC treated with bisphosphonate therapy. Although not all cases have this mutation, once the diagnosis is made, the family should be informed and genetic counseling offered in order to initiate treatment in any other surviving family members with IIAC [12, 15, 18]. Moreover, future pregnancies may require prenatal fetal ultrasound as well as molecular studies to aid in the diagnosis of IIAC in affected families with or without the ENPP1 gene mutation [9].

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper and there have been no significant financial contributions to this work that could have influenced its outcome.

References

  1. S. Guimarães, J. M. Lopes, J. B. Oliveira, and A. Santos, “Idiopathic infantile arterial calcification: a rare cause of sudden unexpected death in childhood,” Pathology Research International, vol. 2010, Article ID 185314, 5 pages, 2010. View at: Publisher Site | Google Scholar
  2. C. R. Chong and G. M. Hutchins, “Idiopathic infantile arterial calcification: the spectrum of clinical presentations,” Pediatric and Developmental Pathology, vol. 11, no. 5, pp. 405–415, 2008. View at: Publisher Site | Google Scholar
  3. N. J. Sebire, A. Ramsay, and M. Sheppard, “Idiopathic arterial calcification presenting with cardiac failure and sudden death in an 11-year-old girl,” Pediatric and Developmental Pathology, vol. 5, no. 4, pp. 412–414, 2002. View at: Publisher Site | Google Scholar
  4. J. J. Moran, “Idiopathic arterial calcification of infancy: a clinicopathologic study,” Pathology Annual, vol. 10, pp. 393–417, 1975. View at: Google Scholar
  5. R. Morton, “Idiopathic arterial calcification in infancy,” Histopathology, vol. 2, no. 6, pp. 423–432, 1978. View at: Google Scholar
  6. S. B. Greenberg and J. Gibson, “New findings in idiopathic arterial calcification of infancy detected by MDCT,” American Journal of Roentgenology, vol. 185, no. 2, pp. 530–532, 2005. View at: Google Scholar
  7. F. Rutsch, P. Böyer, Y. Nitschke et al., “Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy,” Circulation. Cardiovascular genetics, vol. 1, no. 2, pp. 133–140, 2008. View at: Google Scholar
  8. F. Rutsch, S. Vaingankar, K. Johnson et al., “PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification,” American Journal of Pathology, vol. 158, no. 2, pp. 543–554, 2001. View at: Google Scholar
  9. F. K. Nasrallah, H. Baho, A. Sallout, and M. Qurashi, “Prenatal diagnosis of idiopathic infantile arterial calcification with hydrops fetalis,” Ultrasound in Obstetrics and Gynecology, vol. 34, no. 5, pp. 601–604, 2009. View at: Publisher Site | Google Scholar
  10. J. C. Levine, J. Campbell, and A. Nadel, “Prenatal diagnosis of idiopathic infantile arterial calcification,” Circulation, vol. 103, no. 2, pp. 325–326, 2001. View at: Google Scholar
  11. J. del Pizzo, “Focus on diagnosis: congenital infections (TORCH),” Pediatrics in Review, vol. 32, no. 12, pp. 537–542, 2011. View at: Publisher Site | Google Scholar
  12. I. M. van der Sluis, A. M. Boot, M. Vernooij, M. Meradji, and A. A. Kroon, “Idiopathic infantile arterial calcification: clinical presentation, therapy and long-term follow-up,” European Journal of Pediatrics, vol. 165, no. 9, pp. 590–593, 2006. View at: Publisher Site | Google Scholar
  13. G. F. Sholler, J. S. Yu, and P. M. Bale, “Generalized arterial calcification of infancy: three case reports, including spontaneous regression with long-term survival,” Journal of Pediatrics, vol. 105, no. 2, pp. 257–260, 1984. View at: Google Scholar
  14. T. Edouard, G. Chabot, J. Miro et al., “Efficacy and safety of 2-year etidronate treatment in a child with generalized arterial calcification of infancy,” European Journal of Pediatrics, vol. 170, no. 12, pp. 1585–1590, 2011. View at: Publisher Site | Google Scholar
  15. K. A. Ramjan, T. Roscioli, F. Rutsch, D. Sillence, and C. F. Munns, “Generalized arterial calcification of infancy: treatment with bisphosphonates,” Nature Clinical Practice Endocrinology & Metabolism, vol. 5, no. 3, pp. 167–172, 2009. View at: Publisher Site | Google Scholar
  16. G. Ciana, A. Trappan, B. Bembi et al., “Generalized arterial calcification of infancy: two siblings with prolonged survival,” European Journal of Pediatrics, vol. 165, no. 4, pp. 258–263, 2006. View at: Publisher Site | Google Scholar
  17. F. Rutsch, N. Ruf, S. Vaingankar et al., “Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification,” Nature Genetics, vol. 34, no. 4, pp. 379–381, 2003. View at: Publisher Site | Google Scholar
  18. I. G. Kalal, D. Seetha, A. Panda, Y. Nitschke, and F. Rutsch, “Molecular diagnosis of generalized arterial calcification of infancy (GACI),” Journal of Cardiovascular Disease Research, vol. 3, no. 2, pp. 150–154, 2012. View at: Publisher Site | Google Scholar

Copyright © 2014 A. Nael et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views2073
Downloads677
Citations

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.